Ethan Scott Brown died after being wrongly told he would not be eligible to graduate from the University of Glasgow The family of a student who took his own life after being wrongly told he would not be eligible to graduate have said the University of Glasgow “will be held to account”. Ethan Scott Brown, 23, was due to graduate in December 2024 after studying geography. Continue reading...
An estimated 20,000 cases are disclosed to maternity services in England every year. Two survivors tell their stories Evie bought the baby monitor with a rare flicker of enthusiasm, having become increasingly numb as her pregnancy progressed. She liked that it would send video footage to her phone. “I thought, ‘This is really good. Not only can you hear the baby – you can see the baby.’” Unfortunately, her partner appreciated the monitor too. Soon she was carrying it around the house on his orders, so he could watch her. “He used it as surveillance,” she says. By then she was worn down, and terrified. He had become more controlling since they learned she was pregnant. By the seventh month he had become physically abusive, too. “We were just lying in bed watching something,” she recalls of
With eight points from four games, Northern Ireland show real progress through what manager Michael O'Neill calls "one of the most enjoyable windows" he has had in international football.
Amanda Cole says the government needs to weigh the cost of medicines against the damage that a shortage can cause to the NHS and patients Without decisive government action, the reported medicine shortages in hospitals will only be the tip of the iceberg ( Hospitals in England hit by shortages of common drugs such as paracetamol, 29 September ). Medicine supply chains are complex and global, with multiple points of potential failure that are especially sensitive to geopolitical shocks. Brexit has made us even more vulnerable, as we no longer have access to EU medicine reserves , and cross-border logistics are further complicated. Our research shows that these shortages tend to be concentrated in (off-patent) generic and biosimilar markets. It’s true that low prices for off-patent medicines
BOT IS HOT™